Autoimmune Hepatitis Cohort in China

Recruiting Observational Study
Autoimmune Hepatitis
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
14 and older
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
Shanghai Jiao Tong University School of Medicine · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The goal of this observational study is to describe the clinical features and long-term prognosis in patients diagnosed with autoimmune hepatitis (AIH) in China and assess the effectiveness and safety of AIH treatment options in a real-world setting.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥ 14 years * Probable or definite diagnosis of autoimmune hepatitis according to the International Autoimmune Hepatitis Study Group criteria * Availability of all following essential parameters at the initial diagnosis of AIH: including alanine transaminase, aspartate amin…
Contacts

Xiao Xiao, MD

021-68383104

xiaoxiao@renji.com

CONTACT